NSAM
LXRX icon

North Star Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

North Star Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,500
Closed -$15.5K – 356
2025
Q3 		$15.5K Hold
11,500
– – ﹤0.01% 343
2025
Q2 		$10.9K Hold
11,500
– – ﹤0.01% 337
2025
Q1 		$5.3K Hold
11,500
– – ﹤0.01% 319
2024
Q4 		$8.49K Sell
11,500
-1,050
-8% -$1.27K ﹤0.01% 318
2024
Q3 		$19.7K Hold
12,550
– – ﹤0.01% 322
2024
Q2 		$21.1K Hold
12,550
– – ﹤0.01% 311
2024
Q1 		$30.1K Buy
+12,550
New +$27K ﹤0.01% 316

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

North Star Asset Management's LXRX Position: Q4 2025 in Review

North Star Asset Management sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2025, closing a stake of 11,500 shares — an estimated $15.5K sold.

North Star Asset Management first reported a position in LXRX in Q1 2024 and held it in 7 quarters. The position peaked at $30.1K in Q1 2024. 125 funds tracked by Wall St. Rank hold LXRX as of Q4 2025.

  • North Star Asset Management reported no remaining Lexicon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • North Star Asset Management sold 11,500 Lexicon Pharmaceuticals shares in Q4 2025, an estimated $15.5K.
  • North Star Asset Management first reported a position in Lexicon Pharmaceuticals in Q1 2024 and held it in 7 quarters.
  • North Star Asset Management's Lexicon Pharmaceuticals position peaked at $30.1K in Q1 2024.
  • 125 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2025.

Based on North Star Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.